SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-025695
Filing Date
2022-02-02
Accepted
2022-02-02 16:05:58
Documents
14
Period of Report
2022-01-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d296452d8k.htm   iXBRL 8-K 31884
2 EX-10.1 d296452dex101.htm EX-10.1 38814
3 EX-10.2 d296452dex102.htm EX-10.2 38224
  Complete submission text file 0001193125-22-025695.txt   255734

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alna-20220128.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20220128_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20220128_pre.xml EX-101.PRE 11717
8 EXTRACTED XBRL INSTANCE DOCUMENT d296452d8k_htm.xml XML 3477
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 22583632
SIC: 2836 Biological Products, (No Diagnostic Substances)